바이오소재 시장 : 제품 유형별, 최종사용자별, 지역별 - 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

Persistence Market Research has conducted a thorough analysis of the Biomaterials Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Biomaterials Market spanning from 2024 to 2032.

In 2024, the global biomaterials market reached a valuation of US$ 146.83 billion. By 2032, it is projected to soar to US$ 470 billion, experiencing a substantial CAGR of 14.5% from 2024 to 2032.

Key Insights:

• Biomaterials Market Size (2024): US$ 146.83 billion
• Projected Market Value (2032): US$ 470 billion
• Global Market Growth Rate (CAGR 2024-2032): 14.5%

Biomaterials Market - Report Scope:

Biomaterials serve as fundamental components in various medical applications, including implants, prosthetics, tissue engineering, drug delivery systems, and regenerative medicine. The market caters to healthcare industries, research institutions, and academic centers, offering a diverse range of biomaterial types, including metals, ceramics, polymers, and composites.

Market growth is propelled by factors such as increasing prevalence of chronic diseases, aging population, technological advancements in material science, and growing demand for minimally invasive surgical procedures. Moreover, the expanding application of biomaterials in orthopedics, cardiovascular, dental, and ophthalmic surgeries fosters market expansion, driving collaborations between biomaterial manufacturers, medical device companies, and healthcare providers.

Market Growth Drivers:

Rising Demand for Medical Implants: The growing prevalence of orthopedic disorders, cardiovascular diseases, and dental conditions drives the demand for biomaterial-based medical implants, including joint replacements, stents, dental implants, and pacemakers, supporting market growth.

Technological Innovations: Advances in biomaterial synthesis, surface modification techniques, and additive manufacturing technologies enable the development of biocompatible, bioresorbable, and functional biomaterials, enhancing implant performance and patient outcomes.

Regenerative Medicine Applications: Biomaterials play a critical role in tissue engineering, stem cell therapy, and organ transplantation, facilitating tissue regeneration, wound healing, and functional restoration, driving market expansion in regenerative medicine and cell therapy fields.

Market Restraints:

Biocompatibility and Immunogenicity: Ensuring biomaterial biocompatibility, bioactivity, and immunological safety remains a challenge, as implant-host interactions, foreign body responses, and long-term biodegradation properties vary among different biomaterial types and applications.

Regulatory Compliance: Regulatory hurdles related to biomaterial classification, safety assessment, and clinical testing impose compliance burdens on manufacturers, affecting market entry barriers, product development timelines, and commercialization strategies.

Cost and Affordability: The high cost of biomaterial manufacturing, quality control processes, and regulatory approvals pose economic barriers to widespread adoption, particularly in emerging markets with limited healthcare budgets and reimbursement coverage for advanced biomaterial-based therapies.

Market Opportunities:

Personalized Medicine: The advent of personalized medicine and precision healthcare models promotes the development of patient-specific biomaterials, customized implants, and targeted drug delivery systems, addressing individual genetic, physiological, and clinical variability.

Multifunctional Biomaterials: Integration of biomaterials with bioactive molecules, growth factors, and therapeutic agents enables the fabrication of multifunctional implants, smart devices, and controlled-release formulations, enhancing therapeutic efficacy and reducing healthcare costs.

Biofabrication Technologies: Advancements in 3D bioprinting, tissue engineering, and organ-on-a-chip platforms facilitate the fabrication of complex biomimetic structures, vascularized tissues, and organoids, accelerating drug discovery, disease modeling, and personalized regenerative therapies.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the global biomaterials market?
• Which biomaterial types and applications are driving market adoption across different healthcare sectors?
• How are technological advancements reshaping the competitive landscape of the biomaterials market?
• Who are the key players contributing to the biomaterials market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global biomaterials market?

Competitive Intelligence and Business Strategy:

Leading players in the global biomaterials market focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to develop advanced biomaterial formulations, manufacturing processes, and biomedical devices, catering to diverse clinical needs and therapeutic applications. Collaborations with healthcare providers, academic institutions, and regulatory agencies facilitate market access and technology adoption, driving market growth and expansion.

Key Companies Profiled

• Evonik Industries AG
• Medtronic plc
• Carpenter Technology Corporation
• Invibio Ltd.
• Berkeley Advanced Biomaterials
• BASF SE
• Zimmer Biomet Holdings, Inc.
• Stryker
• Covalon Technologies Ltd.
• Johnson & Johnson

Biomaterials Industry Research Segmentation

By Material:

• Metallic Biomaterials
• Ceramic Biomaterials
• Polymeric Biomaterials
• Natural Biomaterials

By Application:

• Dental
• Cardiovascular
• Orthopedic
• Wound Healing
• Neurology
• Surgery

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa"

Table of Contents

1. Executive Summary

• 1.1. Global Biomaterials Market Snapshot, 2023 and 2031
• 1.2. Market Opportunity Assessment, 2024-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. PESTLE Analysis
• 2.6. COVID-19 Impact Analysis
• 2.7. Economic Overview
• 2.8. Regulations and Certifications

3. Macro-economic and Forecast Factors

• 3.1. Global Economic Growth Outlook
• 3.2. GDP Growth Outlook
• 3.3. Global Sectoral Growth Outlook
• 3.4. Other Macroeconomic Factors

4. Global Biomaterials Market Outlook, 2024-2032

• 4.1. Global Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Metallic Biomaterials
    • 4.1.1.2. Ceramic Biomaterials
    • 4.1.1.3. Polymeric Biomaterials
    • 4.1.1.4. Natural Biomaterials
• 4.2. Global Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. Dental
    • 4.2.1.2. Cardiovascular
    • 4.2.1.3. Orthopaedic
    • 4.2.1.4. Wound Healing
    • 4.2.1.5. Neurology
    • 4.2.1.6. Surgery
• 4.3. Global Biomaterials Market Outlook, by Region, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. North America
    • 4.3.1.2. Europe
    • 4.3.1.3. East Asia
    • 4.3.1.4. South Asia & Oceania
    • 4.3.1.5. Latin America
    • 4.3.1.6. Middle East & Africa

5. North America Biomaterials Market Outlook, 2024-2032

• 5.1. North America Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Metallic Biomaterials
    • 5.1.1.2. Ceramic Biomaterials
    • 5.1.1.3. Polymeric Biomaterials
    • 5.1.1.4. Natural Biomaterials
• 5.2. North America Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Dental
    • 5.2.1.2. Cardiovascular
    • 5.2.1.3. Orthopaedic
    • 5.2.1.4. Wound Healing
    • 5.2.1.5. Neurology
    • 5.2.1.6. Surgery
• 5.3. North America Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. U.S.
    • 5.3.1.2. Canada
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Biomaterials Market Outlook, 2024-2032

• 6.1. Europe Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Metallic Biomaterials
    • 6.1.1.2. Ceramic Biomaterials
    • 6.1.1.3. Polymeric Biomaterials
    • 6.1.1.4. Natural Biomaterials
• 6.2. Europe Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Dental
    • 6.2.1.2. Cardiovascular
    • 6.2.1.3. Orthopaedic
    • 6.2.1.4. Wound Healing
    • 6.2.1.5. Neurology
    • 6.2.1.6. Surgery
• 6.3. Europe Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. Germany
    • 6.3.1.2. Italy
    • 6.3.1.3. France
    • 6.3.1.4. U.K.
    • 6.3.1.5. Spain
    • 6.3.1.6. Russia
    • 6.3.1.7. Rest of Europe
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. South Asia & Oceania Biomaterials Market Outlook, 2024-2032

• 7.1. South Asia & Oceania Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Metallic Biomaterials
    • 7.1.1.2. Ceramic Biomaterials
    • 7.1.1.3. Polymeric Biomaterials
    • 7.1.1.4. Natural Biomaterials
• 7.2. South Asia & Oceania Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. Dental
    • 7.2.1.2. Cardiovascular
    • 7.2.1.3. Orthopaedic
    • 7.2.1.4. Wound Healing
    • 7.2.1.5. Neurology
    • 7.2.1.6. Surgery
• 7.3. South Asia & Oceania Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. India
    • 7.3.1.2. Southeast
    • 7.3.1.3. ANZ
    • 7.3.1.4. Rest of South Asia & Oceania
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. East Asia Biomaterials Market Outlook, 2024-2032

• 8.1. East Asia Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Metallic Biomaterials
    • 8.1.1.2. Ceramic Biomaterials
    • 8.1.1.3. Polymeric Biomaterials
    • 8.1.1.4. Natural Biomaterials
• 8.2. East Asia Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Dental
    • 8.2.1.2. Cardiovascular
    • 8.2.1.3. Orthopaedic
    • 8.2.1.4. Wound Healing
    • 8.2.1.5. Neurology
    • 8.2.1.6. Surgery
• 8.3. East Asia Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. China
    • 8.3.1.2. Japan
    • 8.3.1.3. South Korea
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Biomaterials Market Outlook, 2024-2032

• 9.1. Latin America Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 9.1.1. Key Highlights
    • 9.1.1.1. Metallic Biomaterials
    • 9.1.1.2. Ceramic Biomaterials
    • 9.1.1.3. Polymeric Biomaterials
    • 9.1.1.4. Natural Biomaterials
• 9.2. Latin America Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 9.2.1. Key Highlights
    • 9.2.1.1. Dental
    • 9.2.1.2. Cardiovascular
    • 9.2.1.3. Orthopaedic
    • 9.2.1.4. Wound Healing
    • 9.2.1.5. Neurology
    • 9.2.1.6. Surgery
• 9.3. Latin America Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 9.3.1. Key Highlights
    • 9.3.1.1. Brazil
    • 9.3.1.2. Mexico
    • 9.3.1.3. Rest of Latin America
  • 9.3.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Biomaterials Market Outlook, 2024-2032

• 10.1. Middle East & Africa Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 10.1.1. Key Highlights
    • 10.1.1.1. Metallic Biomaterials
    • 10.1.1.2. Ceramic Biomaterials
    • 10.1.1.3. Polymeric Biomaterials
    • 10.1.1.4. Natural Biomaterials
• 10.2. Middle East & Africa Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 10.2.1. Key Highlights
    • 10.2.1.1. Dental
    • 10.2.1.2. Cardiovascular
    • 10.2.1.3. Orthopaedic
    • 10.2.1.4. Wound Healing
    • 10.2.1.5. Neurology
    • 10.2.1.6. Surgery
• 10.3. Middle East & Africa Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
  • 10.3.1. Key Highlights
    • 10.3.1.1. GCC
    • 10.3.1.2. South Africa
    • 10.3.1.3. Turkiye
    • 10.3.1.4. Rest of Middle East and Africa

11. Competitive Landscape

• 11.1. Material Type vs Application Heatmap
• 11.2. Manufacturer vs Material Type Heatmap
• 11.3. Company Market Share Analysis, 2023
• 11.4. Competitive Dashboard
• 11.5. Company Profiles
  • 11.5.1. Evonik Industries AG
    • 11.5.1.1. Company Overview
    • 11.5.1.2. Product Portfolio
    • 11.5.1.3. Financial Overview
    • 11.5.1.4. Business Strategies and Development
  • 11.5.2. Medtronic plc
  • 11.5.3. Carpenter Technology Corporation
  • 11.5.4. Invibio Ltd.
  • 11.5.5. Berkeley Advanced Biomaterials
  • 11.5.6. BASF SE
  • 11.5.7. Covestro AG
  • 11.5.8. Celanese Corporation
  • 11.5.9. Zimmer Biomet Holdings, Inc.
  • 11.5.10. Stryker
  • 11.5.11. Covalon Technologies Ltd.
  • 11.5.12. Johnson & Johnson
  • 11.5.13. DSM Netherlands
  • 11.5.14. Corbion NV
  • 11.5.15. Victrex Plc
  • 11.5.16. Mitsubishi Chemical Group Corporation

12. Appendix

• 12.1. Research Methodology
• 12.2. Report Assumptions
• 12.3. Acronyms and Abbreviations